摘要
目的:探讨早期应用低分子肝素对慢性阻塞性肺疾病急性加重期患者的临床疗效。方法:收治慢性阻塞性肺疾病急性加重期患者100例,随机分为对照组和观察组各50例,对照组采用常规治疗,观察组在对照组基础上早期采用低分子肝素治疗。结果:两组治疗后的Pa CO2、Pa O2、FEV1/FVC、FEV1%pred水平差异均存在统计学意义(P<0.05)。结论:早期应用低分子肝素在慢性阻塞性肺疾病急性加重期患者中效果显著。
Objective:To investigate the clinical effect of low molecular weight heparin on patients with acute exacerbation of chronic obstructive pulmonary disease in early stage.Methods:100 patients with acute exacerbation of chronic obstructive pulmonary disease were selected.They were randomly divided into the control group and the observation group with 50 cases in each group.The control group received routine treatment,while the observation group were given low molecular weight heparin therapy in early stage,based on the teatment given in the control group.Results:After the treatment,the differences in the levels of PaCO2,PaO2,FEV1/FVC and FEV1%pred was statistically significant between groups(P<0.05).Conclusion:Early application of low molecular weight heparin in patients with acute exacerbation of chronic obstructive pulmonary disease has a significant effect.
作者
黄伟
Huang Wei(The Second Department of Internal Medicine,Meili People's Hospital of Changshu City,Jiangsu Province 215511)
出处
《中国社区医师》
2016年第32期23-23,25,共2页
Chinese Community Doctors
关键词
早期
低分子肝素
慢性阻塞性肺疾病急性加重期
Early stage
Low molecular weight heparin
Acute exacerbation of chronic obstructive pulmonary disease
